ExodusPoint Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $42K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.13M | Sell |
|
|||||
|
2023
Q2 | $2.71M | Buy |
|
|||||
|
2023
Q1 | $2.3M | Buy |
|
|||||
|
2022
Q4 | $689K | Sell |
|
|||||
|
2022
Q3 | $1.73M | Buy |
|
|||||
|
2022
Q2 | $1.3M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $546K | Buy |
|
|||||
|
2021
Q3 | $567K | Sell |
|
|||||
|
2021
Q2 | $754K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $322K | Sell |
|
|||||
|
2020
Q3 | $479K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $84K | Sell |
|
|||||
|
2019
Q3 | $149K | Buy |
|
|||||
|
2019
Q2 | $118K | Buy |
|